Robert S. White Joins Board of Directors SANTA CLARA, Calif., July 14, 2020 (GLOBE NEWSWIRE) — Cardiva Medical, Inc, an innovator in the field of vascular closure, today announced the completion of a $45 million equity financing round. The equity round included new investor EW Healthcare Partners in addition to […]
Financial
Orchestra BioMed™ Appoints Drug-Device Combination Expert Jagdish Parasrampuria as Vice President of Pharmaceutical Development
NEW HOPE, Pa., July 13, 2020 (GLOBE NEWSWIRE) — Orchestra BioMed, Inc. (“Orchestra BioMed” or the “Company”), a biomedical innovation company focused on developing transformative therapeutic products for large unmet needs in procedure-based medicine, today announced the appointment of Jagdish Parasrampuria M.Pharm., Ph.D., as Vice President of Pharmaceutical Development. Dr. Parasrampuria […]
Cytokinetics Announces Licensing Collaboration and Royalty Monetization Deals with RTW Investments Focused to CK-3773274, Next-Generation Cardiac Myosin Inhibitor
$250 Million in Committed Capital to Cytokinetics; Additional $200 Million in Development and Commercialization Milestone Payments Ji Xing Pharmaceuticals to Develop & Commercialize in China RTW Provides Access to Capital to Cytokinetics to Fund Global Development in Exchange for Potential Royalties and Agrees to Purchase Royalty on Mavacamten Company to Host […]
Abbott Agrees to Global Transcatheter Litigation Settlement with Edwards Lifesciences
ABBOTT PARK, Ill., July 13, 2020 /PRNewswire/ — Abbott (NYSE: ABT) announced today it has reached an agreement with Edwards Lifesciences Corporation to settle all outstanding patent disputes between the companies in cases related to transcatheter mitral and tricuspid repair products. The agreement will result in the dismissal of all pending cases or appeals […]
Silk Road Medical Promotes Andrew Davis to Newly Created Position of Chief Commercial Officer
SUNNYVALE, Calif., July 09, 2020 (GLOBE NEWSWIRE) — Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced that Andrew Davis has been promoted to Chief Commercial Officer. In this newly created role, Mr. Davis will oversee Silk Road […]
Regeneron to Report Second Quarter 2020 Financial and Operating Results and Host Conference Call and Webcast on August 5, 2020
TARRYTOWN, N.Y., July 8, 2020 /PRNewswire/ — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it will report its second quarter 2020 financial and operating results on Wednesday, August 5, 2020, before the U.S. financial markets open. The Company will host a conference call and simultaneous webcast at 8:30 AM Eastern Time that day. Conference Call InformationTo access […]
Zynex Announces 37% Order Growth and Increases Q2 and Full-Year Revenue Estimates
ENGLEWOOD, Colo., July 9, 2020 /PRNewswire/ — Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in manufacturing and selling non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today announced orders and an increased revenue estimate for Q2 and the full-year 2020. Orders in the second quarter […]
Biotricity Shows Continued Growth through its Preliminary Year-End Guidance and Provides Calendar Second Quarter Update
REDWOOD CITY, Calif., July 08, 2020 (GLOBE NEWSWIRE) — Biotricity Inc. (OTCQB: BTCY), a medical diagnostic and consumer healthcare technology company, today provided guidance on its financial results for the year ended March 31, 2020, announcing that it has experienced increases of approximately 260% in gross annual revenues, year over year, and 113% quarter […]
Eko Appoints New Commercial Leader
Digital health and sales veteran Bryan Humbarger joins cardiac health AI innovator at key growth inflection point OAKLAND, Calif.–(BUSINESS WIRE)–Eko today announced the appointment of digital health sales veteran Bryan Humbarger to the position of Senior Vice President, Commercial. In this role, Mr. Humbarger will oversee sales and commercial operations for […]
Cardurion Pharmaceuticals Announces Appointment of Chris Morabito, M.D., as Chief Medical Officer
Appointment reflects growing strength and diversity of Cardurion’s pipeline BOSTON–(BUSINESS WIRE)–Cardurion Pharmaceuticals, Inc. (Cardurion), a Boston-based, clinical-stage biotechnology company focused on discovering and developing next-generation therapeutics for the treatment of heart failure and other cardiovascular diseases, today announced the appointment of Chris Morabito, M.D., as chief medical officer (CMO). Dr. Morabito […]



